Who is the CEO of Onyx Biotec Ltd?
- Answer Field
-
Sanjay Jain is the CEO, leading strategic and operational growth initiatives
BAJAJ BROKING
Overview of the Company
Onyx Biotec Limited, incorporated in May 2005, specializes in manufacturing sterile water for injections and operates as a pharmaceutical contract manufacturer. With a broad range of dry powder injections and syrups, the company caters to both Indian and international clients. Onyx Biotec’s two manufacturing units, located in Solan, Himachal Pradesh, offer robust production capabilities, delivering high-quality pharmaceutical solutions.
Core Business and Market Position
The company’s core business revolves around supplying sterile injections and providing contract manufacturing services for leading pharmaceutical brands such as Hetero Healthcare and Sun Pharmaceuticals. Boasting certifications like ISO 9001:2015 and ISO 14001:2015, Onyx Biotec has solidified its position as a reputable name in the pharmaceutical sector. Its impressive client list of over 100 firms highlights its market reach and reliability.
The Onyx Biotec IPO will be a fresh issue of 4.81 million shares aggregating to ₹29.34 crores.
IPO Details Table:
Detail | Information |
IPO Open Date | November 13, 2024 |
IPO Close Date | November 18, 2024 |
Listing Exchange | NSE SME |
Price Band | ₹58 to ₹61 per share |
Lot Size | 2000 Shares |
Issue Size | 4,810,000 shares (₹29.34 Cr) |
Purpose of the IPO:
Event | Date |
IPO Open Date | November 13, 2024 |
IPO Close Date | November 18, 2024 |
Basis of Allotment | November 19, 2024 |
Initiation of Refunds | November 20, 2024 |
Credit to Demat | November 20, 2024 |
Listing Date | November 21, 2024 |
Online Application Process:
Key Financial Metrics:
Recent Performance and Growth Prospects:
Potential Risks of Investing in the IPO:
Opportunities and Growth Potential:
KPI | Values |
ROE | 4.99% |
ROCE | 3.71% |
Debt/Equity | 1.21 |
P/BV | 3.1 |
PAT Margin (%) | 12.42% |
Role | Name | Contact Details |
Registrar | Mas Services Limited | Phone: (011) 2610 4142 |
Lead Manager(s) | Horizon Management Private Limited | - |
Onyx Biotec Limited
Bir Plassi, Near Sainimajraropar,
Nalagarh Road, District Solan – 174101,
Phone: +91 172 265 6384
Email: generalinfo@onyxbiotec.com
Website: onyxbiotec.com
The Onyx Biotec IPO presents an opportunity for investors to be part of a growing pharmaceutical player known for its quality and established market reach. While the IPO carries risks typical of the industry, the growth potential and strong client network offer promising returns for informed investors.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Sanjay Jain is the CEO, leading strategic and operational growth initiatives
The IPO opens on November 13, 2024, and closes on November 18, 2024.
The price band is ₹58 to ₹61 per share, based on demand and market valuation.
You can apply by logging into your Bajaj Broking Demat account, selecting the IPO, entering lot details, and completing ASBA or UPI mandate.
Key risks include market competition and regulatory challenges. Rewards stem from growth potential and a strong client network.
Review the RHP, financial statements, and company history for informed decision-making.
Specific lock-up details are not available.
Dividend distribution depends on future profitability and board decisions.
No Result Found
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading